Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2107-0180
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist ; volume:47 ; number:3 ; day:14 ; month:2 ; year:2022 ; pages:371-386 ; date:5.2022
European journal of drug metabolism and pharmacokinetics ; 47, Heft 3 (14.2.2022), 371-386, 5.2022
- Urheber
-
Pusalkar, Sandeepraj
Chowdhury, Swapan K.
Czerniak, Richard
Zhu, Xiaochun
Li, Yuexian
Balani, Suresh K.
Ramsden, Diane
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13318-021-00751-8
- URN
-
urn:nbn:de:101:1-2022071006211090468055
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pusalkar, Sandeepraj
- Chowdhury, Swapan K.
- Czerniak, Richard
- Zhu, Xiaochun
- Li, Yuexian
- Balani, Suresh K.
- Ramsden, Diane
- SpringerLink (Online service)
Ähnliche Objekte (12)
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters
Evaluating drug-drug interaction information in NDF-RT and DrugBank
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
Modelling and simulation techniques to investigate pharmacokinetics, pharmacodynamics, and drug-drug interactions
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
Multi-view feature representation and fusion for drug-drug interactions prediction
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters
Evaluating drug-drug interaction information in NDF-RT and DrugBank
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
Modelling and simulation techniques to investigate pharmacokinetics, pharmacodynamics, and drug-drug interactions
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
Multi-view feature representation and fusion for drug-drug interactions prediction
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters
Evaluating drug-drug interaction information in NDF-RT and DrugBank
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
Modelling and simulation techniques to investigate pharmacokinetics, pharmacodynamics, and drug-drug interactions
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies